Research status on drug prevention and treatment of high altitude sickness
10.13699/j.cnki.1001-6821.2024.11.032
- VernacularTitle:高原病药物预防及治疗的研究现状
- Author:
Qu-Zong ZHAXI
1
;
Luo-Bu GESANG
;
Bai CI
;
Ju HUANG
Author Information
1. 西藏自治区人民医院高原医学研究所,西藏自治区拉萨 850000
- Keywords:
high altitude sickness;
high altitude;
hypoxia
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(11):1689-1692
- CountryChina
- Language:Chinese
-
Abstract:
Altitude sickness is a disease caused by series of physiological and pathological changes and compensatory adaptation changes caused by acute or chronic exposure to high altitude hypoxia.High altitude pulmonary edema(HAPE)and high altitude cerebral edema are life-threatening diseases that are likely to develop;chronic high-altitude sickness,if not taken seriously,can affect various systems of the patient.This article reviews the drug prevention and treatment of three types of altitude sickness,HAPE,high altitude polycythemia(HAPC),and high altitude pulmonary hypertension(HAPH),to provide a reference for the rapid adaptation of people entering high altitudes and the health care of high-altitude residents.
